SecBot SecBot
8-K ·Filed Apr 10, 2026

CVSI

CV Sciences, Inc.
BEARISH
Impact 6/10
Horizondays Processed6mo ago SEC0001193125-26-151228
8-K material event: Items 1.01
Actionable Insight ▼ Bearish

Traders should monitor the company's stock price for potential dilution impact from the lower conversion price and assess the company's ability to service this new debt. The senior secured status of the note means it has priority over other unsecured obligations.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CVSI ▼ -33.33% at T+60d
SHORT call ✓ call won +33.33% · α vs SPY +42.26% · entry $0.0300 → $0.0200
Entry = T+0 close
Apr 10, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.21%
$0.0300
settled 7mo ago
T+5d
0.00%
call 0.00% · α +3.30%
$0.0300
settled 6mo ago
T+20d
0.00%
call 0.00% · α +7.73%
$0.0300
settled 6mo ago
T+60d
-33.33%
call +33.33% · α +42.26%
$0.0200
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

CV Sciences issued a $99,614.04 senior secured convertible note to an institutional investor on April 6, 2026, and amended its existing notes on April 9, 2026, to lower the conversion price to $0.03 per share and extend the maturity date to July 6, 2027. This creates a new financial obligation and modifies existing convertible debt terms.

Key Financial Metrics

Deal Value
$99.6K
Deal Type
credit_facility

Key Facts

  • CV Sciences issued a new $99,614.04 senior secured convertible note on April 6, 2026.
  • The new note has a maturity date of July 6, 2027.
  • On April 9, 2026, the company amended its existing notes to implement a new fixed conversion price of $0.03 per share.
  • The amendment also extended the maturity date of the new note to July 6, 2027.
  • The notes are senior secured obligations with a first lien on all current and future assets of the company and its subsidiaries.

Financial Impact

$99,614.04 new debt issuance with amended terms on existing convertible notes

debtdilutionliquidity

Risk Factors

  • Increased debt burden could strain liquidity
  • Lower conversion price could lead to significant dilution if the note is converted
  • Senior secured status means other creditors have subordinate claims

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-151228
Document: cvsi-20260406.htm0001193125-26-151228
Document: cvsi-ex10_2.htm0001193125-26-151228
Document: 0001193125-26-151228-index-headers.html0001193125-26-151228
Document: 0001193125-26-151228-index.html0001193125-26-151228
Document: 0001193125-26-151228.txt0001193125-26-151228
2 reports for CVSI
Performance horizon
Filters
Rows
Reports for CVSI — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 2/10
$0.0100awaiting T+60—$0.010000 (−0.00%)
Apr 10, 2026
28w ago
8-K
BEARISH ★ 6/10
$0.0300 $0.0200▲ +33.33%▲ +42.26%$0.010000 (+66.67%)
Showing 2 of 2

US Market Status

Market Open — Closes in 6h 25m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026